Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 538

1.

To The Editor.

Miller PD, Bilezikian JP, Lewiecki EM, Watts NB, Carey JJ.

J Bone Miner Res. 2018 Aug 13. doi: 10.1002/jbmr.3566. [Epub ahead of print]

PMID:
30102788
2.

Comparative Effect of rhPTH(1-84) on Bone Mineral Density and Trabecular Bone Score in Hypoparathyroidism and Postmenopausal Osteoporosis.

Cipriani C, Pepe J, Silva BC, Rubin MR, Cusano NE, McMahon DJ, Nieddu L, Angelozzi M, Biamonte F, Diacinti D, Hans D, Minisola S, Bilezikian JP.

J Bone Miner Res. 2018 Jul 24. doi: 10.1002/jbmr.3554. [Epub ahead of print]

PMID:
30088838
3.

AHNS Series: Do you know your guidelines? Optimizing outcomes in reoperative parathyroid surgery: Definitive multidisciplinary joint consensus guidelines of the American Head and Neck Society and the British Association of Endocrine and Thyroid Surgeons.

Stack BC Jr, Tolley NS, Bartel TB, Bilezikian JP, Bodenner D, Camacho P, Cox JPDT, Dralle H, Jackson JE, Morris JC 3rd, Orloff LA, Palazzo F, Ridge JA, Scott-Coombes D, Steward D, Terris DJ, Thompson G, Randolph GW.

Head Neck. 2018 Aug 2. doi: 10.1002/hed.25023. [Epub ahead of print]

PMID:
30070413
4.

Primary Hyperparathyroidism.

Bilezikian JP.

J Clin Endocrinol Metab. 2018 Jul 27. doi: 10.1210/jc.2018-01225. [Epub ahead of print]

PMID:
30060226
5.

The Effects of Long-term Administration of rhPTH(1-84) in Hypoparathyroidism by Bone Histomorphometry.

Rubin MR, Zhou H, Cusano NE, Majeed R, Omeragic B, Gomez M, Nickolas TL, Dempster DW, Bilezikian JP.

J Bone Miner Res. 2018 Jul 4. doi: 10.1002/jbmr.3543. [Epub ahead of print]

PMID:
29972871
6.

Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D.

Sempos CT, Heijboer AC, Bikle DD, Bollerslev J, Bouillon R, Brannon PM, DeLuca HF, Jones G, Munns CF, Bilezikian JP, Giustina A, Binkley N.

Br J Clin Pharmacol. 2018 May 31. doi: 10.1111/bcp.13652. [Epub ahead of print] Review.

PMID:
29851137
7.

ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis.

Bone HG, Cosman F, Miller PD, Williams GC, Hattersley G, Hu MY, Fitzpatrick LA, Mitlak B, Papapoulos S, Rizzoli R, Dore RK, Bilezikian JP, Saag KG.

J Clin Endocrinol Metab. 2018 Aug 1;103(8):2949-2957. doi: 10.1210/jc.2018-00163.

PMID:
29800372
8.

Stop the war on DXA!

Lewiecki EM, Binkley N, Bilezikian JP.

Ann N Y Acad Sci. 2018 Apr 29. doi: 10.1111/nyas.13707. [Epub ahead of print]

PMID:
29707801
9.

IODINE NUTRITION IN THE REPUBLIC OF ARTSAKH (NAGORNO KARABAKH).

Hutchings N, Baghdasaryan S, Qefoyan M, Chiloyan A, Manoukian M, Atayan K, Bilezikian JP.

Endocr Pract. 2018 May;24(5):468-472. doi: 10.4158/EP-2018-0054. Epub 2018 Apr 24.

PMID:
29688765
10.

Epidemiology of hip fracture in Belarus: development of a country-specific FRAX model and its comparison to neighboring country models.

Ramanau H, Chernyanin I, Rudenka E, Lesnyak O, Zakroyeva A, Bilezikian JP, Johansson H, Harvey NC, McCloskey EV, Kanis JA.

Arch Osteoporos. 2018 Apr 17;13(1):42. doi: 10.1007/s11657-018-0454-4.

11.

Primary hyperparathyroidism: recent advances.

Walker MD, Bilezikian JP.

Curr Opin Rheumatol. 2018 Jul;30(4):427-439. doi: 10.1097/BOR.0000000000000511.

PMID:
29664757
12.

Brown tumors of primary hyperparathyroidism may be a source of extrarenal 1,25-dihydroxyvitamin D production.

Sum M, Larner D, Hewison M, Bilezikian JP.

Endocrine. 2018 Jun;60(3):524-527. doi: 10.1007/s12020-018-1579-3. Epub 2018 Mar 19. No abstract available.

PMID:
29556950
13.

Pre-operative localization of abnormal parathyroid tissue by 99mTc-sestamibi in primary hyperparathyroidism using four-quadrant site analysis: an evaluation of the predictive value of vitamin D deficiency.

Tay YD, Yeh R, Kuo JH, McManus C, Lee JA, Bilezikian JP.

Endocrine. 2018 Apr;60(1):36-45. doi: 10.1007/s12020-018-1528-1. Epub 2018 Feb 5.

PMID:
29404903
14.

Trabecular Bone Score in Obese and Nonobese Subjects With Primary Hyperparathyroidism Before and After Parathyroidectomy.

Tay YD, Cusano NE, Rubin MR, Williams J, Omeragic B, Bilezikian JP.

J Clin Endocrinol Metab. 2018 Apr 1;103(4):1512-1521. doi: 10.1210/jc.2017-02169.

PMID:
29373705
15.

New and developing pharmacotherapy for osteoporosis in men.

Gennari L, Bilezikian JP.

Expert Opin Pharmacother. 2018 Feb;19(3):253-264. doi: 10.1080/14656566.2018.1428559. Epub 2018 Jan 19. Review.

PMID:
29350069
16.

Proceedings of the 2017 Santa Fe Bone Symposium: Insights and Emerging Concepts in the Management of Osteoporosis.

Lewiecki EM, Bilezikian JP, Carey JJ, Dell RM, Gordon CM, Harris ST, McClung MR, Miller PD, Rosenblatt M.

J Clin Densitom. 2018 Jan - Mar;21(1):3-21. doi: 10.1016/j.jocd.2017.10.041. Epub 2017 Nov 20. Review.

PMID:
29229501
17.

Initiation of dapagliflozin and treatment-emergent fractures.

Toulis KA, Bilezikian JP, Thomas GN, Hanif W, Kotsa K, Thayakaran R, Keerthy D, Tahrani AA, Nirantharakumar K.

Diabetes Obes Metab. 2018 Apr;20(4):1070-1074. doi: 10.1111/dom.13176. Epub 2018 Jan 8.

PMID:
29193543
18.

Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial.

Bilezikian JP, Hattersley G, Fitzpatrick LA, Harris AG, Shevroja E, Banks K, Leder BZ, Zanchetta JR, Hans D.

Osteoporos Int. 2018 Feb;29(2):323-328. doi: 10.1007/s00198-017-4304-9. Epub 2017 Nov 22.

19.

Epidemiology of fractures in Armenia: development of a country-specific FRAX model and comparison to its surrogate.

Lesnyak O, Sahakyan S, Zakroyeva A, Bilezikian JP, Hutchings N, Babalyan V, Galstyan R, Lebedev A, Johansson H, Harvey NC, McCloskey E, Kanis JA.

Arch Osteoporos. 2017 Nov 7;12(1):98. doi: 10.1007/s11657-017-0392-6.

20.

Recombinant Human Parathyroid Hormone Effect on Health-Related Quality of Life in Adults With Chronic Hypoparathyroidism.

Vokes TJ, Mannstadt M, Levine MA, Clarke BL, Lakatos P, Chen K, Piccolo R, Krasner A, Shoback DM, Bilezikian JP.

J Clin Endocrinol Metab. 2018 Feb 1;103(2):722-731. doi: 10.1210/jc.2017-01471.

PMID:
29099947

Supplemental Content

Loading ...
Support Center